Mayo Clinic is taking epilepsy research in a bold new direction, exploring treatment approaches to help patients living with the most severe and difficult-to-treat forms of epilepsy. About 50 million people worldwide are impacted by epilepsy. Approximately 30% of patients, or about 15 million people, suffer with drug-resistant epilepsy (DRE).
Longevity Medical Instituteā¢ Integrates OncoSeekĀ® to Launch One of Mexico's Most Advanced Cancer Screening Programs
Scientists have unveiled a revolutionary method for mass-producing high-quality human mitochondria, potentially transforming treatments for degenerative diseases. By refining stem cell culture conditions, researchers achieved an extraordinary 854-fold increase in mitochondrial production while significantly enhancing energy output.
A new 3D printed customizable hydrogel performed well in preclinical trials with several different types of meniscal tears
Three Tufts faculty members have been named fellows of the American Association for the Advancement of Science, the worldās largest scientific society. They join 468 other scientists, engineers, and innovators from many scientific disciplines being recognized for their scientific achievements.
Manufacturing engineers are at the forefront of bringing new medicines derived from human sources such as cells, blood and genes to patients. They produce what are often first-of-their kind biotherapies for diseases that previously had few or no treatment options.
A new discovery has shed new light on the crucial role of the CD47 protein in bone fracture healing. Scientists have identified CD47 as an essential regulator of mesenchymal progenitor cell (MSC) proliferationācells critical for bone repair. Without CD47, bone healing was significantly delayed, with reduced callus formation and diminished bone volume in both normal and ischemic fracture models. These findings suggest that targeting CD47 could pave the way for novel therapeutic strategies to enhance fracture recovery, particularly in cases where blood supply is compromised.
New Sanford Burnham Prebys scientist Ahmed Mahmoud, PhD, and his team focus on how to repair adult hearts by restoring the regenerative powers they once possessed early in development. He wants to advance the discoveries he has made in regenerating hearts in mice to develop treatments that may one day benefit patients.
A new study has unveiled the potential of hydrogen-bonding crosslinked supramolecular polymer materials derived from N-acryloyl glycinamide (NAGA). These innovative materials exhibit exceptional mechanical strength, self-healing properties, and tunable functionalities, positioning them as versatile solutions for industries ranging from biomedical engineering to flexible electronics and energy storage.
Researchers from the University of Illinois have identified a key process coordinating liver maturation and polyploidization, a state in which cells carry more than two sets of chromosomes. Their findings provide insight into hepatocyte specialization that will aid efforts in regenerative medicine.
The American Academy of Orthopaedic Surgeons (AAOS) announced Daniel B. F. Saris, MD, PhD, as the inaugural recipient of the Arnold I. Caplan Award for Distinguished Research in Orthobiologics (Caplan Award).
Stromal vascular fraction (SVF) is a complex mixture derived from adipose tissue, consisting of a variety of cells. Due to its potential for tissue repair, immunomodulation, and support of angiogenesis, SVF represents a promising frontier i
Rockville, Md.āThe ARVO Foundation congratulates Mohajeet Bhuckory, PhD (Stanford University) ā the 2024 recipient of the Point of View Award. Established by the Point of View Foundation (FundaciĆ³ Punt de Vista), the award provides a $20,000 cash prize in recognition of an outstanding scholarly article related to efforts to restore vision through regenerative ophthalmology, biotechnology, whole eye transplantation or other approaches.
A pioneering study has unveiled the transformative role of air-liquid interface (ALI) culture in the morphogenesis of hair follicles within skin organoids derived from human-induced pluripotent stem cells (hiPSCs).
Bone regeneration research has taken a significant leap forward with the discovery of a crucial mechanism that could transform treatments for bone disorders. Scientists have identified how Discoidin Domain Receptor 2 (DDR2) enhances Bone Morphogenetic Protein (BMP)-dependent bone regeneration while mitigating the risk of heterotopic ossification (HO), offering promising therapeutic opportunities. This breakthrough sheds light on how DDR2 regulates BMP activity, paving the way for safer and more effective interventions in bone repair and related conditions.
IAn international research team led by the University of California, Irvine has discovered a new type of skeletal tissue that offers great potential for advancing regenerative medicine and tissue engineering.
The Wake Forest Institute for Regenerative Medicine (WFIRM) is part of a major undertaking that will bring together more than 40 scientists, doctors, and industry experts from around the country to make vision-restoring whole eye transplants a reality. The award of up to $56 million is from the Advanced Research Projects Agency for Health (ARPA-H) Transplantation of Human Eye Allografts (THEA) program.
NIH-funded researchers restore facial nerve function in animals with stem cell-based conduits
Investigators from Cedars-Sinai and the University of California, San Francisco (UCSF) have identified a new way to deliver instructions that tell stem cells to grow into specific bodily structures, a critical step in eventually regenerating and repairing tissues and organs.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right